Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
THERE choice im waiting for approval to get real gains . i trust geni and its products
Healthy pull back. Profits profit no harm taking it for some. Top up if you feel the opportunity is good. A lot have bagged haven’t they ?
Punters see 5% profit and they are oot the door ,sad times indeed.
Sellers remorse for many on here in the coming days!
Tech - dependent on your risk appetite
See Dec 27th 2023 RNS latest results and TR1 - AUK.
DYOR
Apologies to this BB
I would think it will double (at least) on unmitigated good FDA news..then, as mentioned, fundraising won't be an issue.
Haven't read enough to know what the chances are of FDA approval. Sometimes FDA come back with extra questions etc.
Just as a reference it was over 17p tbis time last year markets imho are now catching up somewhat
On the other points I think with NHS contract and also some sort of partnership with a big pharma once FDA is approved that will take care of the xtra funding short term my target is around 50 p the market for there products is huge
ATB
Seen June mentioned Tech fwiw.
Nice to have your opinion Tech.
Hi OAPk, cheers for directing me across here.
Just my two-penneth after reading up for a couple of hours..
I'm often reluctant to jump into a share after such a quick rise..
BUT with the company expecting FDA approval "in Q1" I can see why this has risen at this time.
Bit of brinkmanship/hedging going on here I think.
In the Interim Results 2023 presentation at 38 minutes they admit to needing £8 Million funds.
Now the fundraise in December was for half this amount. Just my opinion but I reckon the BOD is hoping for good FDA results then will raise the extra 4 million at higher level.
In the short term I think this is a bit of a gamble on whether FDA approval is fully given and when.
Longer term they seem to have got a good 2025 ahead of them.
Lots happening here great time to hold for the real gains Il take the broker target of 95p with a dose of salts
But 50p this year is very possible and the added bonus of a poss buyout
Wasn’t luck enough to get the low. Last few days have been decent.
Is it FDA approval driving this alone or is there a contract in the pipe for the NHS off the back of NICE approval?
Is GENI talking. ?
The ROCA test uses a proprietary algorithm to calculate a woman's individual OC risk based on several clinical factors including age and accumulating Cancer Antigen 125 (CA-125) blood test results. The ability of the ROCA test to interpret changes in an individual's CA-125 level over time through four monthly interval testing was recognised by the NICE committee as an important contributor to its accuracy and ability to detect OC earlier. Additionally, the NICE committee recognised the published evidence that surveillance using the ROCA test would have a cost-saving benefit for the NHS.
Partnership once FDA is given also imho
People waking up to a share that will do very well this year!
I think it will exceed all these targets short term. What do we know though, the market will decide!
Nice place to be right now though.
17p this time last year without FDA and expanding European networks
Very cheap with what is ahead
Market cap 13mill is crazy live products growing revs and fda approval any day.
Think that's poss but 1 bag minimum imho
GOT A FEELING AND LOOKING AT TRADES this will hit 8p bid this week .LOOKING AT 20P IF APPROVED now from 12/15
Market catching on this far to cheap as this was over 25p a year ago without the FDA on the doorstep
Lots of buying today approval imminent Thursdsy RNS always nice time to release positive news 20p min on FDA approval.
Once aproval is given I can't see this company staying independent the valuation and money potential of the product will omjo attract a takeoutfrom a big pharma
Tqhussian and swizzydog kind thanks .I wish i added more at 3.6 when i did . IT WAS like free money .All the best here .
You can't look it up as it is a De Novo submission and so there is a lot go company - FDA liaison and discussion so only open to the company and their agents with specific log in etc. If you read the De Novo pathway it explains it a bit clearer. We should have an update this month hopefully.
I couldn’t find it on there.